Informations techniques
Exploitant
Laboratoires PROSTRAKAN PHARMA
Présentation
DROLEPTAN 2,5 mg/ 1ml, solution injectable (IV) B/10 - CIP 561 122-8
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
HAY3dLzB7n6jkEcm